| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -53.8K | 100% | $11.26 | -$605K |
| Net | -8 | -53.8K | -100% | -$605K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jay R. Luly | President and CEO, Director | $10.1M | -$69.6K | -0.69% | Feb 12, 2024 |
| Yat Sun Or | Chief Scientific Officer | $4.63M | -$23.2K | -0.5% | Feb 12, 2024 |
| Paul J. Mellett | Chief Fin. & Admin Officer | $1.19M | -$23.2K | -1.91% | Feb 12, 2024 |
| Nathaniel S. Gardiner | Chief Legal Officer | $1M | -$23.2K | -2.26% | Feb 26, 2024 |
| Brendan Luu | Chief Business Officer | $485K | -$20.5K | -4.05% | Feb 12, 2024 |
| Tara Lynn Kieffer | Chief Product Strategy Officer | $399K | -$110K | -21.6% | Jun 17, 2024 |
| Nathalie Adda | Sr. VP & Chief Medical Officer | $319K | Apr 1, 2022 | ||
| Scott T. Rottinghaus | Chief Medical Officer | $239K | -$196K | -45% | Jul 11, 2024 |
| Terry Vance | Director | $52.9K | -$139K | -72.5% | Mar 6, 2024 |
| Mark G. Foletta | Director | Mar 6, 2024 | |||
| Lesley Russell | Director | Mar 6, 2024 | |||
| Kristine Peterson | Director | Mar 6, 2024 | |||
| Matthew Paul Kowalsky | Chief Legal Officer | Apr 29, 2024 | |||
| L. Carter Bruce | Director | Mar 6, 2024 | |||
| Yujiro Hata | Director | Mar 6, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|